FRENCH TECH: A Promising Start for the New Line of Medication Safety Robots AIDE in France
Deenova, the Franco-Italian group and Europe's leading provider of medication safety automation solutions for hospitals and long-term care facilities, is pleased to announce the signing of two new contracts for the supply of its latest range of AIDE automated systems.
The first contract was signed with the Charles Perrens Hospital in Bordeaux to supply the AIDE-CUT, Deenova's drug safety automation system for tablet cutting and repackaging of all types of drugs. When repackaging unit dose medications, the AIDE-CUT ensures maximum accuracy and safety. The system is outfitted with high-tech sensors that detect and correct errors in real time, ensuring that the cutting and repackaging processes are optimized.
The second contract was signed with the Paul Reig Retirement Home in Banyuls, France, for the supply of the AIDE-PICK, Deenova's personalized therapy preparation automation system for the distribution of treatments to patients. The AIDE-PICK improves patient safety, reduces medication errors, and maximizes operational efficiency by ensuring full medication traceability, allowing nurses to spend more time with patients and less time preparing therapies.
Initially launched in 2013, the AIDE line of automated dispensers has been updated over the course of 2022-2023 to integrate modules that allow for the automatic repackaging and dispensing of all forms of medication, including sachets, ampoules, pre-filled syringes and vials. The new AIDE line will be presented at the French-speaking hospital pharmacy congress Hopipharm, which will be held this year from May 24 to 26 at the Strasbourg Congress Centre (Stand 79).
“These contracts are a testament to our customers' confidence in our ability to provide innovative and reliable solutions that improve the safety and efficiency of medication management,” said Loїc Bessin, AIDE solutions designer and managing director of Deenova France, adding, “With less than a year after the launch of our AIDE line, we already have six installations planned for 2023.”
With these two new contracts, Deenova reinforces its leadership position in the French medication safety automation market, as Christophe Jaffuel, member of the Board of Directors and Chief Commercial Officer of the Deenova Group, explains: “After 10 years of leadership in the French market with the ACCED automated system, the successful launch of our new AIDE modular range is very promising for the future of our company.”
About Deenova
Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.
For more information on Deenova’s market-leading solutions, visit www.deenova.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230509005708/en/
Contact information
Christophe Jaffuel, c.jaffuel@deenova.com,
Martina Buccianti, m.buccianti@deenova.com, +39 0523 785311
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Forecasting, Monitoring and KI – Swarm Intelligence for the Energy Transition at EM-Power Europe1.6.2023 12:26:00 EEST | Press release
The energy transition does not just change the energy generation technologies we use, but also requires the power grids to be updated. Today, instead of a dozen large-scale power plants, an enormous swarm of power plants all feed into our grid: Several thousand wind farms and over 2.6 million PV systems have been installed in Germany alone – and there is a steep upward trend. This makes our power generation weather dependent: On windless or cloudy days, the energy supply may not match the demand, leading to bottlenecks – or worse – blackouts. To keep the grid frequency at a stable 50.2 hertz, grid operators need yield forecasts. Artificial intelligence (AI) helps process this highly complex information and integrate it into the energy system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005572/en/ EM-Power Europe Exhibition (Photo: Solar Promotion GmbH) With millions of solar installations, wallboxes and heat pumps,
European 100 Study Reveals: Despite Year-over-Year Improvements, Tremendous Opportunity to Enhance Hiring with AI, Automation and Experience Remains1.6.2023 12:00:00 EEST | Press release
Phenom released the second annual European Edition of its State of Candidate Experience Report, revealing significant improvement in the use of AI over one year and shining a spotlight on enormous opportunities for companies to enhance job seekers’ experiences through intelligence and automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005156/en/ ‘State of Candidate Experience: 2023 Benchmarks Report — European Edition’ reveals, despite year-over-year improvements, tremendous opportunity to enhance hiring with AI, automation and experience remains. The second annual report provides recommendations, including small steps for making big impacts. (Photo: Business Wire) Phenom audited the top 100 European companies of the Global 500 list in three key areas of the talent journey: attraction, engagement and conversion, as well as the use of AI. By viewing their strengths, weaknesses and opportunities for improvement,
In Industry First, PUMA Creates Sustainability Report Podcast Series to Reach Out to Gen-Z1.6.2023 11:00:00 EEST | Press release
Sports company PUMA has created a podcast series to make its 2022 Sustainability Report more accessible and to reach a wider and younger audience. The RE:GEN REPORTS podcast features next-generation thinkers from six countries and distills the content of the report into 10 podcast episodes, of which the first three are available on all major podcast platforms on June 1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005537/en/ Sports company PUMA has created a podcast series to make its 2022 Sustainability Report more accessible and to reach a wider and younger audience. (Photo: Business Wire) The RE:GEN REPORTS podcast, as well as the recently announced Voices of a Re:Generation project, comes as a direct result of the feedback PUMA received at last year’s Conference of the People, which the company organized to discuss solutions for some of the fashion industry’s most pressing sustainability challenges with Gen-Z rep
invoX Pharma Increases Investment in pHion Therapeutics to Further Develop Next Generation of mRNA Vaccines1.6.2023 11:00:00 EEST | Press release
invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline of innovative products, today announced that it has completed a second tranche of investment in pHion Therapeutics (“pHion”), a next-generation mRNA vaccine company. The transaction supports invoX’s strategy to be a fully integrated biopharmaceutical company and its ongoing commitment to deliver innovative life-saving therapies pHion is developing a pipeline of therapeutic and prophylactic vaccines focussed on oncology and infectious diseases. The company’s proprietary RALA platform can deliver anionic molecules such as mRNA and saRNA in a stealth-like way, evading detection, to generate a potent antigen-specific CD8+ T-cell response. The RALA peptide-based drug delivery system is based on a sequence of 30 amino acids which condenses anionic cargo, irrespective of size, into nanoparticles that are highly efficient at cellular
AVEVA Recognized as a Leader in the IDC MarketScape: Worldwide Process Manufacturing Execution System 2023 Vendor Assessment1.6.2023 10:00:00 EEST | Press release
AVEVA, a global leader in industrial software, driving digital transformation and sustainability, announced that it has been positioned in the Leaders Category in the IDC MarketScape: Worldwide Process Manufacturing Execution System 2023 Vendor Assessment (doc # EUR150526323, April 2023). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005060/en/ Keith Chambers, Vice-President, Operations Management Software, AVEVA. (Photo: Business Wire) According to the IDC MarketScape, “AVEVA MES is a model-driven solution that supports the modelling of operational workflows, production processes, and equipment. This configurable business process management approach enables standardization of operational processes across multisite operations and provides a centralized management platform for data analysis with visualization.” In explaining the strengths of AVEVA MES, the report said, “The model-driven and process-based approach have
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom